The latest closing stock price for Aligos Therapeutics as of September 18, 2024 is 14.16.
An investor who bought $1,000 worth of Aligos Therapeutics stock at the IPO in 2020 would have $-46 today, roughly 0 times their original investment - a -1.18% compound annual growth rate over 4 years.
The all-time high Aligos Therapeutics stock closing price was 34.94 on January 20, 2021.
The Aligos Therapeutics 52-week high stock price is 19.50, which is 37.7% above the current share price.
The Aligos Therapeutics 52-week low stock price is 0.35, which is 97.5% below the current share price.
The average Aligos Therapeutics stock price for the last 52 weeks is 1.85.
An investor who bought $1,000 worth of Aligos Therapeutics stock at the IPO in 2020 would have $-46 today, roughly 0 times their original investment - a -1.18% compound annual growth rate over 4 years.
The all-time high Aligos Therapeutics stock closing price was 34.94 on January 20, 2021.
The Aligos Therapeutics 52-week high stock price is 19.50, which is 37.7% above the current share price.
The Aligos Therapeutics 52-week low stock price is 0.35, which is 97.5% below the current share price.
The average Aligos Therapeutics stock price for the last 52 weeks is 1.85.